Tao-Hsin Tung1, Xiao-Qing Lin2, Yan Chen2, Mei-Xian Zhang1, Jian-Sheng Zhu2. 1. Evidence-based Medicine Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China. 2. Department of Infectious Diseases, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, China.
Abstract
PURPOSE: This population-based study aimed to determine the willingness to receive a booster dose of vaccine against coronavirus disease (COVID-19) in Taizhou, China. METHODS: An online questionnaire investigation addressing participants' willingness to receive a booster dose of the COVID-19 vaccine was organized in Taizhou, China. Of the 2318 interviewees who received the invitation, 1576 finished a qualifying questionnaire, corresponding to a response rate of 68.0%. RESULTS: The majority of respondents (n = 1435 [91.1%]) were willing to accept a booster vaccination against COVID-19. History of allergic reaction to other vaccines (OR = 0.30), confidence in the safety of the COVID-19 vaccines (OR = 3.20), confidence in the effectiveness of the COVID-19 vaccines against SARS-CoV-2 (OR = 2.25) and its variants (useful versus [vs.] useless, OR = 2.33), and vaccine recipients (OR = 3.09) remained significantly associated with willingness to accept a booster dose of COVID-19 vaccines. CONCLUSION: A moderate proportion of the participants who responded were willing to receive a booster dose of the COVID-19 vaccine. These results are valuable for starting health education and interventions to accelerate vaccine uptake and improve public health outcomes during the COVID-19 pandemic in China.
PURPOSE: This population-based study aimed to determine the willingness to receive a booster dose of vaccine against coronavirus disease (COVID-19) in Taizhou, China. METHODS: An online questionnaire investigation addressing participants' willingness to receive a booster dose of the COVID-19 vaccine was organized in Taizhou, China. Of the 2318 interviewees who received the invitation, 1576 finished a qualifying questionnaire, corresponding to a response rate of 68.0%. RESULTS: The majority of respondents (n = 1435 [91.1%]) were willing to accept a booster vaccination against COVID-19. History of allergic reaction to other vaccines (OR = 0.30), confidence in the safety of the COVID-19 vaccines (OR = 3.20), confidence in the effectiveness of the COVID-19 vaccines against SARS-CoV-2 (OR = 2.25) and its variants (useful versus [vs.] useless, OR = 2.33), and vaccine recipients (OR = 3.09) remained significantly associated with willingness to accept a booster dose of COVID-19 vaccines. CONCLUSION: A moderate proportion of the participants who responded were willing to receive a booster dose of the COVID-19 vaccine. These results are valuable for starting health education and interventions to accelerate vaccine uptake and improve public health outcomes during the COVID-19 pandemic in China.
Authors: Mostafa Saidur Rahim Khan; Trinh Xuan Thi Nguyen; Sumeet Lal; Somtip Watanapongvanich; Yoshihiko Kadoya Journal: Int J Environ Res Public Health Date: 2022-06-08 Impact factor: 4.614
Authors: Ryan C Lee; Howard Hu; Eric S Kawaguchi; Andre E Kim; Daniel W Soto; Kush Shanker; Jeffrey D Klausner; Sarah Van Orman; Jennifer B Unger Journal: Prev Med Rep Date: 2022-06-27